{"schema_version":"1","generated_at":"2026-10-28T10:03:26.073Z","data_as_of":null,"url":"https://www.findmykol.com/kol/daniel-halperin","json_url":"https://www.findmykol.com/kol/daniel-halperin/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"daniel-halperin","name":"Daniel Halperin","credential":"MD","specialty":"Medical Oncology","specialty_raw":"Medical Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"institution":"The University of Texas MD Anderson Cancer Center","institution_url":"https://www.findmykol.com/institution/the-university-of-texas-md-anderson-cancer-center","city":"Houston","state":"TX","region":{"label":"South Central","url":"https://www.findmykol.com/region/south-central"}},"identifiers":{"npi":"1801024161","orcid":"0000-0002-3113-930X","openalex":"A5012619170"},"summary":"Daniel Halperin is an Oncology physician affiliated with The University of Texas MD Anderson Cancer Center. OpenAlex indexes 333 publications with 8,058 citations (h-index 29); ClinicalTrials.gov lists 2 registered studies matched to this name.","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":333,"cited_by_count":8058,"h_index":29,"latest_activity_year":2025,"source":"works"},"trials":{"count":2,"shown":3,"withheld":0,"matched_by":"investigator name, confirmed against institution and geography","rows":[{"nct":"NCT04776876","title":"Retifanlimab (INCMGA00012) and Telotristat Ethyl for the Treatment of Advanced Neuroendocrine Tumors and Carcinoid Syndrome","phase":"PHASE2","status":"WITHDRAWN","role":"Overall official","sponsor":"M.D. Anderson Cancer Center","source_url":"https://clinicaltrials.gov/study/NCT04776876","trial_url":"https://www.findmykol.com/trial/NCT04776876"},{"nct":"NCT03817866","title":"Chromogranin A as Blood Marker in Cancer Patients","status":"COMPLETED","role":"Overall official","sponsor":"Brahms AG","source_url":"https://clinicaltrials.gov/study/NCT03817866","trial_url":"https://www.findmykol.com/trial/NCT03817866"},{"nct":"NCT02101918","title":"Ziv-Aflibercept in Treating and Computed Tomography Perfusion Imaging in Predicting Response in Patients With Pancreatic Neuroendocrine Tumors That Are Metastatic or Cannot Be Removed by Surgery","phase":"PHASE2","status":"COMPLETED","role":"Overall official","sponsor":"National Cancer Institute (NCI)","source_url":"https://clinicaltrials.gov/study/NCT02101918","trial_url":"https://www.findmykol.com/trial/NCT02101918"}],"source":"trials"},"payments":{"company_count":12,"program_years":{"first":2021,"last":null},"rows_total":20,"shown":3,"withheld":17,"rows":[{"payer":"Boehringer Ingelheim Pharmaceuticals, Inc.","program_year":2025,"amount_usd":10769.45,"payment_count":17,"source_url":"https://openpaymentsdata.cms.gov/search?query=1801024161"},{"payer":"Exelixis Inc.","program_year":2025,"amount_usd":6874.53,"payment_count":7,"source_url":"https://openpaymentsdata.cms.gov/search?query=1801024161"},{"payer":"ABBVIE INC.","program_year":2025,"amount_usd":5955,"payment_count":4,"source_url":"https://openpaymentsdata.cms.gov/search?query=1801024161"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1801024161","source":"payments"},"publications":{"total":50,"shown":5,"withheld":45,"matched_by":"OpenAlex author record","recent":[{"title":"Epidemiology of Neuroendocrine Neoplasms in the US","year":2025,"journal":"JAMA Network Open","source_url":"https://doi.org/10.1001/jamanetworkopen.2025.15798","status":"verified"},{"title":"[<sup>177</sup>Lu]Lu-DOTA-TATE in newly diagnosed patients with advanced grade 2 and grade 3, well-differentiated gastroenteropancreatic neuroendocrine tumors: Primary analysis of the phase 3 randomized NETTER-2 study.","year":2024,"journal":"Journal of Clinical Oncology","source_url":"https://doi.org/10.1200/jco.2024.42.3_suppl.lba588","status":"verified"},{"title":"Delta-like ligand 3 (DLL3) landscape in pulmonary and extra-pulmonary neuroendocrine neoplasms","year":2024,"journal":"npj Precision Oncology","source_url":"https://doi.org/10.1038/s41698-024-00739-y","status":"verified"},{"title":"International Prognostic Score for Nodular Lymphocyte–Predominant Hodgkin Lymphoma","year":2024,"journal":"Journal of Clinical Oncology","source_url":"https://doi.org/10.1200/jco.23.01655","status":"verified"},{"title":"Transformation of G1-G2 neuroendocrine tumors to neuroendocrine carcinomas following peptide receptor radionuclide therapy","year":2024,"journal":"Endocrine Related Cancer","source_url":"https://doi.org/10.1530/erc-23-0203","status":"verified"}],"source":"works"},"contact":{"address_1":"1515 HOLCOMBE BLVD","city":"Houston","state":"TX","zip":"770304009","phone":"713-792-6161","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1801024161","source":"identity"},"similar":[{"name":"Hagop Kantarjian","slug":"hagop-kantarjian","institution":"The University of Texas MD Anderson Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/hagop-kantarjian","json_url":"https://www.findmykol.com/kol/hagop-kantarjian/profile.json"},{"name":"Gabriel Hortobagyi","slug":"gabriel-hortobagyi","institution":"The University of Texas MD Anderson Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/gabriel-hortobagyi","json_url":"https://www.findmykol.com/kol/gabriel-hortobagyi/profile.json"},{"name":"Jaffer Ajani","slug":"jaffer-ajani","institution":"The University of Texas MD Anderson Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/jaffer-ajani","json_url":"https://www.findmykol.com/kol/jaffer-ajani/profile.json"},{"name":"Funda Meric-Bernstam","slug":"funda-meric-bernstam","institution":"The University of Texas MD Anderson Cancer Center","specialty":"Surgery","url":"https://www.findmykol.com/kol/funda-meric-bernstam","json_url":"https://www.findmykol.com/kol/funda-meric-bernstam/profile.json"},{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"},{"name":"Larry Norton","slug":"larry-norton","institution":"Memorial Sloan Kettering Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/larry-norton","json_url":"https://www.findmykol.com/kol/larry-norton/profile.json"}],"coverage":{"note":"A basic record from the physician directory. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"payments":17,"publications":45}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2015-06-09","collected_at":"2026-10-27T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"}},"methodology_url":"https://www.findmykol.com/about#methodology"}